Important Notice
Abbott does not endorse any of the centers on this locator, but merely provides them as a reference tool for patients seeking to locate an LVAD center with training and/or experience on Abbott’s HeartMate IITM LVAD and/or the HeartMate 3TM LVAD. Abbott does not represent that this locator includes all centers that perform LVAD implantations. None of the centers listed have paid or received any fees to be included in this locator. Note that Abbott is a medical device manufacturer and cannot provide medical advice.Abbott does not verify or monitor the performance, licensure, certification, quality or qualifications of any LVAD center listed in the database and is not responsible for the medical advice, care or treatment provided by the LVAD centers included in this database.
The decision whether, and when, to contact an LVAD center is yours. When choosing an LVAD center, we encourage you to weigh various factors, which may include the recommendation of your doctor, experience of the LVAD center, and any other criteria you deem relevant.
For information on the approved use, risks, and benefits of the HeartMate IITM LVAD and the HeartMate 3TM LVAD, click here.
By accessing and using the Find a HeartMate LVAD Center database, you acknowledge that you understand and agree with the information set forth above.
INDICATIONS AND IMPORTANT SAFETY INFORMATION
Rx Only
Brief Summary: Prior to using these devices, please review the Instructions For Use for a complete listing of indications, contraindications, warnings, precautions, potential adverse events and directions for use.
HeartMate 3™ LVAS Indications: The HeartMate 3 Left Ventricular Assist System is indicated for providing short- and long-term mechanical circulatory support (e.g., as bridge to transplant or myocardial recovery, or destination therapy) in patients with advanced refractory left ventricular heart failure.
HeartMate II™ LVAS Indications: The HeartMate II Left Ventricular Assist System is indicated for use as a “bridge to transplantation” for cardiac transplant candidates who are at risk of imminent death from non-reversible left ventricle failure. It is also indicated for use in patients with New York Heart Association (NYHA) Class IIIB or IV end-stage left ventricular failure, who have received optimal medical therapy for at least 45 of the last 60 days, and who are not candidates for cardiac transplantation. The HeartMate II Left Ventricular Assist System is intended for use both inside and outside of the hospital, or for transportation of Left Ventricular Assist Device patients via ground ambulance, airplane, or helicopter.
HeartMate 3 and HeartMate II LVAS Contraindications: The HeartMate 3 and HeartMate II Left Ventricular Assist Systems are contraindicated for patients who cannot tolerate, or who are allergic to, anticoagulation therapy.
HeartMate 3 and HeartMate II LVAS Adverse Events: Adverse events that may be associated with the use of the HeartMate 3 or HeartMate II Left Ventricular Assist System include, but are not limited to those listed below: death, bleeding, cardiac arrhythmia, localized infection, right heart failure, respiratory failure, device malfunctions, driveline infection, renal dysfunction, sepsis, stroke, other neurological event (not stroke-related), hepatic dysfunction, psychiatric episode, venous thromboembolism, hypertension, arterial non-central nervous system (CNS), thromboembolism, pericardial fluid collection, pump pocket or pseudo pump pocket infection, myocardial infarction, wound dehiscence, hemolysis (not associated with suspected device thrombosis) and pump thrombosis.